Details for Patent: 8,859,504
✉ Email this page to a colleague
Which drugs does patent 8,859,504 protect, and when does it expire?
Patent 8,859,504 protects NINLARO and is included in one NDA.
This patent has one hundred and twenty-four patent family members in thirty-seven countries.
Summary for Patent: 8,859,504
| Title: | Boronate ester compounds and pharmaceutical compositions thereof |
| Abstract: | The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases. |
| Inventor(s): | Elliott; Eric L. (Watertown, MA), Ferdous; Abu J. (Nottingham, MD), Kaufman; Michael J. (Lexington, MA), Komar Lay; Sonja A. (Belmont, MA), Mazaik; Debra L. (Holliston, MA), McCubbin; Quentin J. (Belmont, MA), Nguyen; Phuong M. (Cambridge, MA), Palaniappan; Vaithianathan (Andover, MA), Skwierczynski; Raymond D. (Andover, MA), Truong; Nobel T. (Milford, MA), Varga; Csanad M. (Newton, MA), Zawaneh; Peter N. (Brookline, MA) |
| Assignee: | Millennium Pharmaceuticals, Inc. (Cambridge, MA) |
| Application Number: | 13/667,164 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,859,504 |
|
Patent Claim Types: see list of patent claims | Compound; Composition; |
Drugs Protected by US Patent 8,859,504
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Takeda Pharms Usa | NINLARO | ixazomib citrate | CAPSULE;ORAL | 208462-001 | Nov 20, 2015 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |||
| Takeda Pharms Usa | NINLARO | ixazomib citrate | CAPSULE;ORAL | 208462-002 | Nov 20, 2015 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |||
| Takeda Pharms Usa | NINLARO | ixazomib citrate | CAPSULE;ORAL | 208462-003 | Nov 20, 2015 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,859,504
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 072162 | ⤷ Try a Trial | |||
| Argentina | 095554 | ⤷ Try a Trial | |||
| Argentina | 095566 | ⤷ Try a Trial | |||
| Argentina | 100011 | ⤷ Try a Trial | |||
| Australia | 2009260778 | ⤷ Try a Trial | |||
| Brazil | 122014008750 | ⤷ Try a Trial | |||
| Brazil | 122014008753 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
